F.D.A. Approves Repatha, a Second Drug for Cholesterol in a Potent New Class

F.D.A. Approves Repatha, a Second Drug for Cholesterol in a Potent New Class

The new drug is made by Amgen for people with extremely high cholesterol levels and heart patients who do not get adequate results from statins and other therapies.

Read More…